Department of Pharmaceutical Sciences , University of Kentucky , Lexington , Kentucky 40508 , United States.
Department of Structural Biology , St. Jude Children's Research Hospital , Memphis , Tennessee 38105 , United States.
J Med Chem. 2019 Sep 26;62(18):8429-8442. doi: 10.1021/acs.jmedchem.9b00410. Epub 2019 Sep 13.
Chemical control of cullin neddylation is attracting increased attention based largely on the successes of the NEDD8-activating enzyme (E1) inhibitor pevonedistat. Recently reported chemical probes enable selective and time-dependent inhibition of downstream members of the neddylation trienzymatic cascade including the co-E3, DCN1. In this work, we report the optimization of a novel class of small molecule inhibitors of the DCN1-UBE2M interaction. Rational X-ray co-structure enabled optimization afforded a 25-fold improvement in potency relative to the initial screening hit. The potency gains are largely attributed to additional hydrophobic interactions mimicking the N-terminal acetyl group that drives binding of UBE2M to DCN1. The compounds inhibit the protein-protein interaction, block NEDD8 transfer in biochemical assays, engage DCN1 in cells, and selectively reduce the steady-state neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification.
基于 NEDD8-激活酶(E1)抑制剂 pevonedistat 的成功,对 Cullin 连接酶的化学调控引起了越来越多的关注。最近报道的化学探针能够选择性地和时间依赖性地抑制连接酶三联酶级联反应的下游成员,包括共 E3、DCN1。在这项工作中,我们报告了一类新型小分子抑制剂的优化,这些抑制剂能够抑制 DCN1-UBE2M 相互作用。合理的 X 射线共结构使优化后的效力相对于初始筛选命中提高了 25 倍。这些效力的提高主要归因于额外的疏水性相互作用,模拟了驱动 UBE2M 与 DCN1 结合的 N 端乙酰基。这些化合物抑制蛋白-蛋白相互作用,在生化测定中阻断 NEDD8 的转移,在细胞中与 DCN1 结合,并选择性地降低两种鳞状癌细胞系中 Cul1 和 Cul3 的稳态连接酶水平,这两种细胞系都扩增了 DCN1。